TULEX PHARMS INC FDA Approval ANDA 210125

ANDA 210125

TULEX PHARMS INC

FDA Drug Application

Application #210125

Application Sponsors

ANDA 210125TULEX PHARMS INC

Marketing Status

Prescription001

Application Products

001TABLET;ORAL5MG0OXYBUTYNIN CHLORIDEOXYBUTYNIN CHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2018-09-06STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

TULEX PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210125
            [companyName] => TULEX PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"OXYBUTYNIN CHLORIDE","activeIngredients":"OXYBUTYNIN CHLORIDE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/06\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-09-06
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.